A bill on Monday (September 9), the U.S. House of Representatives, aims to restrict the business exchanges between China Pharmaceutical Kangde, Huada Gene and several other biotechnology companies on the grounds of national security.
Comprehensive Reuters and Bloomberg reported that the House of Representatives Supervision Committee proposed the biological safety law proposal passed by 40 votes to 1 vote in May.Dazhizong, Huada -made American subsidiary Complete Genomics, Yaoming Kangde and Yaoming creatures.
The bill will prohibit the signing of federal contracts with the target company and the company with business exchanges with them.
The US House of Representatives passed the Biosaisp for 81 votes on Monday on Monday with 306 votes.The bill must be passed in the Senate before being sent to President Biden to sign a law.
This is also the successful bill of adoption of the Tiktok through the adoption of the byte beating this year, otherwise it is about to be blocked by the United States, and once again waved a great stick to Chinese companies.
Proposal supporters believe that this effort is related to whether China will occupy a dominant position in another field of the United States.They are worried that Beijing may develop biological weapons or use biological data obtained from overseas in other ways.
Huada Gene and other companies said that the biological safety law is based on false and misleading allegations and will restrict competition; at the same time, it will deny any threat to US national security.
